Article

Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms.

Vascular Diseases Research Unit, The Institute of Cardiovascular Research, Ninewells Hospital and Medical School, Dundee, Scotland DD1 9SY, UK.
Free Radical Biology and Medicine (Impact Factor: 5.71). 10/2005; 39(5):584-9. DOI: 10.1016/j.freeradbiomed.2005.04.020
Source: PubMed

ABSTRACT The aetiology of chronic fatigue syndrome (CFS) is unknown; however, recent evidence suggests excessive free radical (FR) generation may be involved. This study investigated for the first time levels of 8-iso-prostaglandin-F(2 alpha)-isoprostanes alongside other plasma markers of oxidative stress in CFS patients and control subjects. Forty-seven patients (18 males, 29 females, mean age 48 [19--63] years) who fulfilled the Centres for Disease Control classification for CFS and 34 healthy volunteers (13 males, 21 females, 46 [19--63] years) were enrolled in the study. The CFS patients were divided into two groups; one group had previously defined cardiovascular (CV) risk factors of obesity and hypertension (group 1) and the second were normotensive and nonobese (group 2). Patients had significantly increased levels of isoprostanes (group 1, P=0.007; group 2, P=0.03, unpaired t test compared to controls) and oxidised low-density lipoproteins (group 2, P=0.02) indicative of a FR attack on lipids. CFS patients also had significantly lower high-density lipoproteins (group 1, P=0.011; group 2, P=0.005). CFS symptoms correlated with isoprostane levels, but only in group 2 low CV risk CFS patients (isoprostanes correlated with; total symptom score P=0.005; joint pain P=0.002; postexertional malaise P=0.027, Pearson). This is the first time that raised levels of the gold standard measure of in vivo oxidative stress (isoprostanes) and their association with CFS symptoms have been reported.

Download full-text

Full-text

Available from: Vance Spence, Jul 08, 2015
0 Followers
 · 
140 Views
  • Source
    • "ng HMGB1 , and indirectly stimu - late the production of secondary DAMP signaling ( Lotze et al . , 2007 ) . Interestingly , approximately 40% of all FDA - approved anticancer drugs have been shown to induce ROS ( Chen et al . , 2007 ) . Oxidative stress can produce behavioral toxicities , such as chronic fatigue syndrome ( Logan and Wong , 2001 ; Kennedy et al . , 2005 ) , mild cognitive impairment ( Fukui et al . , 2002 ; Pratico et al . , 2002 ) , and diabetic neuropathy ( Nagamatsu et al . , 1995 ; Low et al . , 1997 ; Vincent et al . , 2004 ) . Furthermore , there is evidence to suggest that chemotherapy - induced neuropathy ( Areti et al . , 2014 ) and cognitive impairment ( Aluise et al . , 2010"
    [Show abstract] [Hide abstract]
    ABSTRACT: While chemotherapeutic agents have yielded relative success in the treatment of cancer, patients are often plagued with unwanted and even debilitating side-effects from the treatment which can lead to dose reduction or even cessation of treatment. Common side effects (symptoms) of chemotherapy include (i) cognitive deficiencies such as problems with attention, memory and executive functioning; (ii) fatigue and motivational deficit; and (iii) neuropathy. These symptoms often develop during treatment but can remain even after cessation of chemotherapy, severely impacting long-term quality of life. Little is known about the underlying mechanisms responsible for the development of these behavioral toxicities, however, neuroinflammation is widely considered to be one of the major mechanisms responsible for chemotherapy-induced symptoms. Here, we critically assess what is known in regards to the role of neuroinflammation in chemotherapy-induced symptoms. We also argue that, based on the available evidence, neuroinflammation is unlikely the only mechanism involved in the pathogenesis of chemotherapy-induced behavioral toxicities. We evaluate two other putative candidate mechanisms. To this end we discuss the mediating role of damage-associated molecular patterns (DAMPs) activated in response to chemotherapy-induced cellular damage. We also review the literature with respect to possible alternative mechanisms such as a chemotherapy-induced change in the bioenergetic status of the tissue involving changes in mitochondrial function in relation to chemotherapy-induced behavioral toxicities. Understanding the mechanisms that underlie the emergence of fatigue, neuropathy, and cognitive difficulties is vital to better treatment and long-term survival of cancer patients.
    Frontiers in Neuroscience 05/2015; 9. DOI:10.3389/fnins.2015.00131
  • Source
    • "A high level of ROS within the body, either through over production of ROS or decreased levels of antioxidants and antioxidant enzyme activity, leads to cell damage, altering functions through interruption of cellular signaling and membranes, resulting from disruption of synthesizing proteins, lipids and DNA bases (Chow, 1991, 2009; Spurlock and Savage, 1993). Oxidative stress involves in the development of many diseases in humans, such as cancer, Parkinson's disease, Alzheimer's disease, heart failure and chronic fatigue syndrome (Singh et al., 1995; Cooke et al., 2003; Kennedy et al., 2005; Halliwell, 2007; Valko et al., 2007). 2007; Wang et al., 2010). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Abstract: Heat stress (HS) causes oxidative damage, increasing mortality and reducing productivity in chickens. The objective of this study was to determine the benefits of antioxidant supplementation in laying hens during HS. Eighty 32-week-old W-36 White Leghorn hens were used in this study. Hens were randomly pair-housed in two adjacent rooms and fed a control diet (CF) or control diet mixed with Agrado Plus Ultra , ® an antioxidant, at 160 mg/kg (AF) for two weeks. One room was then subjected to a hot climate (H) (33°C) for 8 days. Physical and physiological data were collected at day 1 and 8 during the treatment. Core body temperature was increased (p<0.0001) and BW (p<0.05) and liver weight (p<0.0001) were reduced in laying hens regardless of treatment. However, compared to its respective controls, the concentrations of heat shock protein 70 (HSP70) were increased in H-AF hens (p< 0.01) but not in H-CF hens (p>0.05) at 8 days during the process of HS. Similarly, HSP70 mRNA expression tended to increase in H-AF hens only (p = 0.09). Heat stress reduced the concentrations of total CO2 and bicarbonate (p<0.05), indicating respiratory alkalosis and decreased vitamin A (p<0.01), vitamin E (p<0.0001) and glutathione peroxidase (p<0.05) concentrations but increased protein carbonyl concentrations (p<0.05), indicating protein oxidative damage. A temperature by feed interaction was observed in the concentrations of partial pressure CO2 (pCO2, p<0.05), superoxide dismutase (SOD, p = 0.06) and protein carbonyl (p = 0.1). Heat stress-caused decreases in pCO2 and SOD and increases in protein carbonyl concentrations were found in control hens but not in AF hens. These results suggest antioxidant supplementation attenuates oxidative stress response in laying hens. These data support the hypothesis that supplemental antioxidants improve hen well-being by reducing HS associated physical and physiological damage.
    International Journal of Poultry Science 01/2014; 13(5):260-271.
  • Source
    • "A final metabolic step frees the isoprostanes from the cell membrane phospholipids, allowing them to move into body fluids, where they can be measured to provide an objective and reliable measure for the presence of oxidative stress. This model is pertinent to CFS for the following reasons: first, two studies have reported that isoprostanes are elevated in CFS (Kennedy et al., 2005; Robinson et al., 2009). And second , we have found that cortical GSH is reduced by 36% in CFS (Shungu et al., 2012). "
    [Show abstract] [Hide abstract]
    ABSTRACT: We have been able to reduce substantially patient pool heterogeneity by identifying phenotypic markers that allow the researcher to stratify chronic fatigue syndrome (CFS) patients into subgroups. To date, we have shown that stratifying based on the presence or absence of comorbid psychiatric diagnosis leads to a group with evidence of neurological dysfunction across a number of spheres. We have also found that stratifying based on the presence or absence of comorbid fibromyalgia leads to information that would not have been found on analyzing the entire, unstratified patient group. Objective evidence of orthostatic intolerance (OI) may be another important variable for stratification and may define a group with episodic cerebral hypoxia leading to symptoms. We hope that this review will encourage other researchers to collect data on discrete phenotypes in CFS to allow this work to continue more broadly. Finding subgroups of CFS suggests different underlying pathophysiological processes responsible for the symptoms seen. Understanding those processes is the first step toward developing discrete treatments for each.
    Frontiers in Physiology 05/2013; 4:109. DOI:10.3389/fphys.2013.00109 · 3.50 Impact Factor